These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22189597)

  • 1. Inhibition of 3-methylcrotonyl-CoA carboxylase explains the increased excretion of 3-hydroxyisovaleric acid in valproate-treated patients.
    Luís PB; Ruiter JP; IJlst L; Diogo L; Garcia P; de Almeida IT; Duran M; Wanders RJ; Silva MF
    J Inherit Metab Dis; 2012 May; 35(3):443-9. PubMed ID: 22189597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproic acid utilizes the isoleucine breakdown pathway for its complete β-oxidation.
    Luís PB; Ruiter JP; Ofman R; Ijlst L; Moedas M; Diogo L; Garcia P; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochem Pharmacol; 2011 Dec; 82(11):1740-6. PubMed ID: 21843514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of isovaleryl-CoA dehydrogenase and short branched-chain acyl-CoA dehydrogenase in the metabolism of valproic acid: implications for the branched-chain amino acid oxidation pathway.
    Luís PB; Ruiter JP; Ijlst L; Tavares de Almeida I; Duran M; Mohsen AW; Vockley J; Wanders RJ; Silva MF
    Drug Metab Dispos; 2011 Jul; 39(7):1155-60. PubMed ID: 21430231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal metabolic model for 3-methylcrotonyl-CoA carboxylase deficiency.
    Rodríguez JM; Ruíz-Sala P; Ugarte M; Peñalva MA
    J Biol Chem; 2004 Feb; 279(6):4578-87. PubMed ID: 14612443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and intramitochondrial levels of valproyl-coenzyme A metabolites.
    Silva MF; Ruiter JP; IJlst L; Allers P; ten Brink HJ; Jakobs C; Duran M; Tavares de Almeida I; Wanders RJ
    Anal Biochem; 2001 Mar; 290(1):60-7. PubMed ID: 11180937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of leucine in fibroblasts from patients with deficiencies in each of the major catabolic enzymes: branched-chain ketoacid dehydrogenase, isovaleryl-CoA dehydrogenase, 3-methylcrotonyl-CoA carboxylase, 3-methylglutaconyl-CoA hydratase, and 3-hydroxy-3-methylglutaryl-CoA lyase.
    Yoshida I; Søvik O; Sweetman L; Nyhan WL
    J Neurogenet; 1985 Dec; 2(6):413-24. PubMed ID: 3841150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproyl-dephosphoCoA: a novel metabolite of valproate formed in vitro in rat liver mitochondria.
    Silva MF; Ijlst L; Allers P; Jakobs C; Duran M; de Almeida IT; Wanders RJ
    Drug Metab Dispos; 2004 Nov; 32(11):1304-10. PubMed ID: 15483197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the extra-mitochondrial CoA -ester formation of valproic and Delta4 -valproic acids.
    Aires CC; Ruiter JP; Luís PB; ten Brink HJ; Ijlst L; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochim Biophys Acta; 2007 Apr; 1771(4):533-43. PubMed ID: 17321204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated biotin-resistant 3-methylcrotonyl-CoA carboxylase deficiency: long-term outcome in a case with neonatal onset.
    Lehnert W; Niederhoff H; Suormala T; Baumgartner ER
    Eur J Pediatr; 1996 Jul; 155(7):568-72. PubMed ID: 8831079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete beta-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase.
    Silva MF; Ruiter JP; Overmars H; Bootsma AH; van Gennip AH; Jakobs C; Duran M; Tavares de Almeida I; Wanders RJ
    Biochem J; 2002 Mar; 362(Pt 3):755-60. PubMed ID: 11879205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal metabolic model for type I 3-methylglutaconic aciduria.
    Rodríguez JM; Ruíz-Sala P; Ugarte M; Peñalva MA
    J Biol Chem; 2004 Jul; 279(31):32385-92. PubMed ID: 15181004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and liver tissue biotinidase enzyme activity in rats which were administrated to valproic acid.
    Korkmazer N; Vurucu S; Demirkaya E; Unay B; Kul M; Akin R; Gokcay E
    Brain Dev; 2006 Sep; 28(8):515-20. PubMed ID: 16682156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproyl-CoA inhibits the activity of ATP- and GTP-dependent succinate:CoA ligases.
    Luís PB; Ruiter J; IJlst L; de Almeida IT; Duran M; Wanders RJ; Silva MF
    J Inherit Metab Dis; 2014 May; 37(3):353-7. PubMed ID: 24154984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproyl-CoA and esterified valproic acid are not found in brains of rats treated with valproic acid, but the brain concentrations of CoA and acetyl-CoA are altered.
    Deutsch J; Rapoport SI; Rosenberger TA
    Neurochem Res; 2003 Jun; 28(6):861-6. PubMed ID: 12718439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights on the mechanisms of valproate-induced hyperammonemia: inhibition of hepatic N-acetylglutamate synthase activity by valproyl-CoA.
    Aires CC; van Cruchten A; Ijlst L; de Almeida IT; Duran M; Wanders RJ; Silva MF
    J Hepatol; 2011 Aug; 55(2):426-34. PubMed ID: 21147182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial metabolism of valproic acid.
    Li J; Norwood DL; Mao LF; Schulz H
    Biochemistry; 1991 Jan; 30(2):388-94. PubMed ID: 1988037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis.
    Aires CC; Ijlst L; Stet F; Prip-Buus C; de Almeida IT; Duran M; Wanders RJ; Silva MF
    Biochem Pharmacol; 2010 Mar; 79(5):792-9. PubMed ID: 19854160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive excretion of 2-oxoglutaric acid and 3-hydroxyisovaleric acid in a patient with a deficiency of 3-methylcrotonyl-CoA carboxylase.
    Finnie MD; Cottrall K; Seakins JW; Snedden W
    Clin Chim Acta; 1976 Dec; 73(3):513-9. PubMed ID: 1000869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS.
    Silva MF; Selhorst J; Overmars H; van Gennip AH; Maya M; Wanders RJ; de Almeida IT; Duran M
    Clin Biochem; 2001 Nov; 34(8):635-8. PubMed ID: 11849623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats.
    Grillo MP; Chiellini G; Tonelli M; Benet LZ
    Drug Metab Dispos; 2001 Sep; 29(9):1210-5. PubMed ID: 11502730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.